Table 3.
Preoperative serum value of CA125 and He4 biomarkers: absolute value and risk estimation according to predefined cut-off (in relation to hormonal status for He4) (only for CA125: Group_A versus Group_B).
| Number | Mean value | Standard deviation | P value | ||
|---|---|---|---|---|---|
| Preoperative CA125 serum value (UI/L) | Group_A | 43 | 52.92 | 83.26 | n.s |
| Group_B | 70 | 56.32 | 71.85 | ||
|
| |||||
| Preoperative He4 serum value (pmol/L) | Group_A | 43 | 89.99 | 175.07 | — |
| Group_B | — | — | — | ||
|
| |||||
| Category | Number (%) | P value | |||
|
| |||||
| CA125 cut-off value | Group_A | 43 | Over | 15 (34.9) | n.s |
| Under | 28 (65.1) | ||||
| Group_B | 70 | Over | 37 (52.9) | ||
| Under | 33 (47.1) | ||||
|
| |||||
| He4 cut-off value | Group_A | 43 | Over | 24 (55.8) | — |
| Under | 19 (44.2) | ||||
| — | — | — | — | ||
| — | — | ||||
|
| |||||
| ROMA score cut-off value | Group_A | 43 | Over | 13 (30.2) | — |
| Under | 30 (69.8) | ||||
| — | — | — | — | ||
| — | — | ||||